Literature DB >> 11055742

Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season.

.   

Abstract

On July 14, CDC reported a substantial delay in the availability of a proportion of influenza vaccine for the 2000-01 season and the possibility of a vaccine shortage. Since then, resolution of manufacturing problems and improved yields of the influenza A (H3N2) vaccine component have averted a shortage. Although safe and effective influenza vaccine will be available in similar quantities as last year, much of the vaccine will be distributed later in the season than usual. This update provides information on the influenza vaccine supply situation and updated influenza vaccination recommendations by the Advisory Committee on Immunization Practices (ACIP) for the 2000-01 influenza season.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055742

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Preventing influenza: vaccine systems and practices in the Southeast.

Authors:  Julie A Gazmararian; Walter A Orenstein; Pascale Wortley; James A Buehler; Lisa Elon; Jeffrey P Koplan; Laura Schild; Tonya Dixon; Paul Weiss; David S Stephens
Journal:  Public Health Rep       Date:  2006 Nov-Dec       Impact factor: 2.792

2.  Effects of mass media coverage on timing and annual receipt of influenza vaccination among Medicare elderly.

Authors:  Byung-Kwang Yoo; Margaret L Holland; Jay Bhattacharya; Charles E Phelps; Peter G Szilagyi
Journal:  Health Serv Res       Date:  2010-10       Impact factor: 3.402

3.  Does sex influence immunization status for influenza and pneumonia in older veterans?

Authors:  Bevanne Bean-Mayberry; Elizabeth M Yano; Maria K Mor; Nichole K Bayliss; Xiangyan Xu; Michael J Fine
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

4.  A national survey of physician practices regarding influenza vaccine.

Authors:  Matthew M Davis; Shawn R McMahon; Jeanne M Santoli; Benjamin Schwartz; Sarah J Clark
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

5.  Influenza and pneumococcal vaccination demand responses to changes in infectious disease mortality.

Authors:  Ying-Chun Li; Edward C Norton; William H Dow
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

6.  Prescription of antibiotics in Riga and Vilnius tertiary children's hospitals.

Authors:  Inese Sviestina; Vytautas Usonis; Vilija Gurksniene; Sigita Burokiene; Inga Ivaskeviciene; Dzintars Mozgis
Journal:  Eur J Hosp Pharm       Date:  2017-03-22

7.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

Authors:  Suzanne L Epstein; Terrence M Tumpey; Julia A Misplon; Chia-Yun Lo; Lynn A Cooper; Kanta Subbarao; Mary Renshaw; Suryaprakash Sambhara; Jacqueline M Katz
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

8.  Occurrence of invasive pneumococcal disease and number of excess cases due to influenza.

Authors:  Katarzyna Grabowska; Liselotte Högberg; Pasi Penttinen; Ake Svensson; Karl Ekdahl
Journal:  BMC Infect Dis       Date:  2006-03-20       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.